CATALYST PHARMACEUTICALS INC. - COMMON STOCK

21.48

22-November-24 16:44:58

15 minutes delayed

Stocks

+0.36

+1.70%

Today's range

21.05 - 21.55

ISIN

N/A

Source

NASDAQ

NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

19 Aug 2024 10:26:35 By NetDania Notify
NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

16 Aug 2024 10:11:28 By NetDania Notify
NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

15 Aug 2024 14:15:01 By NetDania Notify
NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

13 Aug 2024 09:45:04 By NetDania Notify
NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

12 Aug 2024 15:05:33 By NetDania Notify
NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

09 Aug 2024 10:22:00 By NetDania Notify
NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

08 Aug 2024 12:28:33 By NetDania Notify
Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update

07 Aug 2024 16:11:34 By Nasdaq GlobeNewswire
NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

24 Jul 2024 09:55:10 By NetDania Notify
Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada

24 Jul 2024 08:05:00 By Nasdaq GlobeNewswire
NetDania - New 12 months High: CATALYST PHARMACEUTICALS INC. - COMMON STOCK

23 Jul 2024 10:55:07 By NetDania Notify
Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024

22 Jul 2024 08:03:00 By Nasdaq GlobeNewswire
Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®

30 May 2024 13:41:21 By Nasdaq GlobeNewswire
Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024

28 May 2024 08:03:00 By Nasdaq GlobeNewswire
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update

08 May 2024 16:16:20 By Nasdaq GlobeNewswire
Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024

01 May 2024 08:00:01 By Nasdaq GlobeNewswire
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024

22 Apr 2024 08:00:00 By Nasdaq GlobeNewswire
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day

28 Mar 2024 08:03:00 By Nasdaq GlobeNewswire
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium

27 Mar 2024 08:03:00 By Nasdaq GlobeNewswire
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)

13 Mar 2024 07:55:00 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.